Similar articles for PMID: 22575449

Year	Number of Results
1995	1
1997	1
1998	2
1999	1
2000	1
2002	1
2003	6
2004	6
2005	7
2006	3
2007	10
2008	7
2009	1
2010	3
2011	4
2012	3
2013	4
2014	3
2015	1
2016	1
2017	2
2018	1
2020	3
2023	1
2024	0

1

Proteasomal insensitivity of apoptin in tumor cells.

Lanz HL, Suijker J, Noteborn MH, Backendorf C. Lanz HL, et al. Biochem Biophys Res Commun. 2012 May 25;422(1):169-73. doi: 10.1016/j.bbrc.2012.04.132. Epub 2012 Apr 30. Biochem Biophys Res Commun. 2012. PMID: 22575449

2

Differential sensitivity of breast cancer and melanoma cells to proteasome inhibitor Velcade.

Yerlikaya A, Erin N. Yerlikaya A, et al. Int J Mol Med. 2008 Dec;22(6):817-23. Int J Mol Med. 2008. PMID: 19020781

3

Development and application of an in vitro apoptin kinase assay.

Lanz HL, Florea BI, Noteborn MH, Backendorf C. Lanz HL, et al. Anal Biochem. 2012 Feb 1;421(1):68-74. doi: 10.1016/j.ab.2011.10.030. Epub 2011 Oct 22. Anal Biochem. 2012. PMID: 22080040

4

Effect of noncompetitive proteasome inhibition on bortezomib resistance.

Li X, Wood TE, Sprangers R, Jansen G, Franke NE, Mao X, Wang X, Zhang Y, Verbrugge SE, Adomat H, Li ZH, Trudel S, Chen C, Religa TL, Jamal N, Messner H, Cloos J, Rose DR, Navon A, Guns E, Batey RA, Kay LE, Schimmer AD. Li X, et al. J Natl Cancer Inst. 2010 Jul 21;102(14):1069-82. doi: 10.1093/jnci/djq198. Epub 2010 May 26. J Natl Cancer Inst. 2010. PMID: 20505154

5

Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells.

Kraus M, Rückrich T, Reich M, Gogel J, Beck A, Kammer W, Berkers CR, Burg D, Overkleeft H, Ovaa H, Driessen C. Kraus M, et al. Leukemia. 2007 Jan;21(1):84-92. doi: 10.1038/sj.leu.2404414. Epub 2006 Oct 5. Leukemia. 2007. PMID: 17024115

6

Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells.

Fuchs D, Berges C, Opelz G, Daniel V, Naujokat C. Fuchs D, et al. J Cell Biochem. 2008 Jan 1;103(1):270-83. doi: 10.1002/jcb.21405. J Cell Biochem. 2008. PMID: 17516511

7

[Molecular mechanism of specific induction of apoptosis in tumor cells by apoptin].

Wang QM, He FC. Wang QM, et al. Ai Zheng. 2005 Apr;24(4):509-12. Ai Zheng. 2005. PMID: 15820081 Review. Chinese.

8

Apoptin: therapeutic potential of an early sensor of carcinogenic transformation.

Backendorf C, Visser AE, de Boer AG, Zimmerman R, Visser M, Voskamp P, Zhang YH, Noteborn M. Backendorf C, et al. Annu Rev Pharmacol Toxicol. 2008;48:143-69. doi: 10.1146/annurev.pharmtox.48.121806.154910. Annu Rev Pharmacol Toxicol. 2008. PMID: 17848136 Review.

9

Evidence that mitogen-activated protein kinase phosphatase-1 induction by proteasome inhibitors plays an antiapoptotic role.

Small GW, Shi YY, Edmund NA, Somasundaram S, Moore DT, Orlowski RZ. Small GW, et al. Mol Pharmacol. 2004 Dec;66(6):1478-90. doi: 10.1124/mol.104.003400. Epub 2004 Sep 24. Mol Pharmacol. 2004. PMID: 15448190

10

Amino acid starvation sensitizes cancer cells to proteasome inhibition.

Mizrachy-Schwartz S, Cohen N, Klein S, Kravchenko-Balasha N, Levitzki A. Mizrachy-Schwartz S, et al. IUBMB Life. 2010 Oct;62(10):757-63. doi: 10.1002/iub.377. IUBMB Life. 2010. PMID: 20931634 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

65 results

Results by year